MedTrace Logo

Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

NCT00899509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2017-08-08

No results posted yet for this study

Summary

This research trial studies deoxyribonucleic acid (DNA) in tumor tissue from women with node-positive breast cancer to see if genetic factors are related to the patient's response to chemotherapy. DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment with certain chemotherapy drugs.

Conditions

Interventions

OTHER

laboratory biomarker analysis

correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Minetta C. Liu, MD · Lombardi Comprehensive Cancer Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899509 on ClinicalTrials.gov